Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-430-1 | CAS number: 6746-94-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The experimental phase of the study was undertaken between 3 and 17 March 1997.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Principles of method if other than guideline:
- The method followed was based on that described in the EEC Methods for the determination of toxicity, Annex to Directive 92/69/EEC (OJ No. L383A, 29.12.92), Part B, Method B.3. Acute toxicity (dermal).
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 425-430-1
- EC Name:
- -
- Cas Number:
- 6746-94-7
- Molecular formula:
- C5 H6
- IUPAC Name:
- ethynylcyclopropane
- Details on test material:
- - Name of test material (as cited in study report): EthynyI cyclopropane (SD 957)
- Physical state: Colourless liquid
- Analytical purity: 97-100 %
- Lot/batch No.: 3590-129-D4
- Expiration date of the lot/batch: January 1999
- Storage condition of test material: -20°C, under nitrogen and in the dark
- Intended use: Pharmaceutical intermediate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Ltd, Bicester, Oxon, England
- Age at study initiation: 7 to 10 weeks
- Weight at study initiation: 239 to 296 g
- Fasting period before study: no data
- Diet: standard laboratory rodent diet (RM 1(E) SQC) ad libitum
- Water: drinking water ad libitum
- Acclimation period: for a minimum period of five days prior to the start of the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 15
- Air changes (per hr): 10 to 15
- Photoperiod (hrs dark / hrs light): 12/12
The batch(s) of diet used for the study was analysed for certain nutrients, possible contaminants and microorganisms.
Administration / exposure
- Type of coverage:
- occlusive
- Details on dermal exposure:
- ADMINISTRATION OF TEST SUBSTANCE
One day prior to treatment, hair was removed from the dorso-lumbar region of each rat with electric clippers taking care to avoid damaging the skin, exposing an area equivalent to approximately 10% of the total body surface area.
The test substance was applied by spreading it evenly over the prepared skin. The treatment area (approximately 50 mm x 50 mm) was covered with porous gauze. To reduce the likelihood of evaporation of test material from the treatment site the gauze was kept in place and protected by a sheet of aluminium foil. These were held in place with a non irritating dressing, and further covered by a waterproof dressing encircled firmly around the trunk of the animal.
Treatment in this manner was performed on Day 1(day of dosing) of the study only. At the end of the 24 hours exposure period the dressings were carefully removed and the treated area of skin was washed with warm water (30° to 40°C) to remove any residual test substance. The treated area was blotted dry with absorbent paper.
TEST SUBSTANCE PREPARATION
SD 957 was administered, as supplied by the Sponsor, at a volume of 2.56 ml/kg bodyweight (specific gravity 0.7825) to achieve a dose concentration of 2000 mg/kg. A sub-sample of SD 957 was transported just prior to, dosing in a closed container at ambient temperature from the Department of formulation to the animal holding area. In the main phase of the study, the test substance was retained in a fume cupboard housed in a walk-in ventilated cabinet which was separated from the cabinets in the main room in which the animals were housed.
The absorption of the test substance was not determined.
Characterisation of the homogeneity, stability and purity of the test substance was not undertaken in this study and remains the responsibility of the sponsor. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bodyweight (the EU limit dose) .
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: twice daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
OBSERVATIONS
Mortality
Cages of rats were checked at least twice daily for any mortalities.
Clinical signs
Animals were observed soon after dosing and at approximately hourly intervals for the remainder of Day 1. On subsequent days animals were observed once in the morning and again at the end of the experimental day (with the exception of Day 15 - morning only). The nature and severity of the clinical
signs and time were recorded at each observation.
Dermal responses
Local dermal irritation at the treatment site was assessed daily using the following numerical scoring system:
Erythema and eschar formation:
0 No erythema
1 Slight erythema
2 Well defined erythema
3 Moderate erythema
4 Severe erythema (beet redness) to slight eschar formation (injuries in depth)
Oedema formation:
0 No oedema
1 Slight oedema
2 Well-defined oedema (edges of area well-defined by definite raising)
3 Moderate oedema (raised approximately 1 millimeter)
4 Severe oedema (raised more than 1 millimeter and extending beyond the area of exposure)
Bodyweight
The bodyweight of each rat was recorded on Days 1(prior to dosing), 8 and 15. Individual weekly bodyweight changes and group mean bodyweights were calculated.
TERMINAL STUDIES
Termination
All animals were killed on Day 15 by cervical dislocation.
Macroscopic pathology
All animals were subjected to a macroscopic examination which consisted of opening the thoracic and abdominal cavities. The cranial cavity was not examined as observations did not indicate neurotoxic activity. The macroscopic appearance of all examined organs, was recorded and macroscopic
abnormalities (in this instance the treatment site) were preserved.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- There were no deaths in a group of ten rats (five males and five females) following a single dermal application of SD 957 at a dose level of 2000 mg/kg bodyweight.
- Clinical signs:
- other: There were no signs of systemic reaction to treatment.
- Gross pathology:
- No abnormalities were observed at the study termination necropsy .
Any other information on results incl. tables
The acute lethal dermal dose to rats of SD 957 was demonstrated to be greater than 2000 mg/kg bodyweight .
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.